D5M-32390-98533
3 vaccinations
9 coded responses
15 check-ins
9 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 968 / HI
- Registered
- 2022-01-08
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-25
Dose 1 — Pfizer-BioNTech
-
2021-03-18
Dose 2 — Pfizer-BioNTech
-
2022-01-07
Dose 3 — Pfizer-BioNTech
-
2022-01-08
Registered in v-safe
-
2022-01-08
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-09
Survey response — days 1–6 daily, dose 3MedDRA: Axillary pain, Discomfort — Feeling: Fair · Site: Pain · Fever · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Armpit pain/discomfortMedDRA releases: 2024-11 · check-in free text available
-
2022-01-10
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Swollen lymph nodes (armpit) continueMedDRA releases: 2024-11 · check-in free text available
-
2022-01-11
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Continued swollen lymph nodes (armpit)MedDRA releases: 2024-11 · check-in free text available
-
2022-01-12
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Slight swelling of lymph nodes (armpit)MedDRA releases: 2024-11 · check-in free text available
-
2022-01-13
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Fatigue or tirednessFree text: Continuing swollen lymph nodes (armpit) but much smaller, almost unnoticeableMedDRA releases: 2024-11 · check-in free text available
- 2022-01-14
-
2022-01-21
Survey response — day 14, dose 3MedDRA: Arthralgia, Back pain — Feeling: FairFree text: Pain in left shoulder & mid-back.MedDRA releases: 2024-11 · check-in free text available
-
2022-01-29
Survey response — day 21, dose 3MedDRA: Anxiety, Chest discomfort, Fatigue, Insomnia, Migraine, Office visit — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professionalFree text: Symptoms: Tiredness, insomnia, chest tightness (anxiety), migraine · Healthcare visit (other): in-person appointmentMedDRA releases: 2024-11 · check-in free text available
-
2022-01-29
Report sent to call center — day 21, dose 3Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-02-04
- 2022-02-11
-
2022-02-18
Survey response — day 42, dose 3MedDRA: Anxiety, Migraine, Office visit — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Higher anxiety, a migraine (which I never get) · Healthcare visit (other): regular in-office appointmentMedDRA releases: 2024-11 · check-in free text available
-
2022-02-18
Report sent to call center — day 42, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2022-02-23
- 2022-04-08
-
2022-07-08
Survey response — 6 months, dose 3MedDRA: Migraine — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: MigraineMedDRA releases: 2024-11 · check-in free text available
-
2022-07-08
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-07-11
- 2022-07-11
- 2022-07-11
-
2022-07-14
Call successfulDoes not wish to fill out VAERS report
-
2022-07-14
Call successfulDoes not wish to fill out VAERS report
-
2022-07-14
Call successfulDoes not wish to fill out VAERS report
- 2023-01-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-25 | Pfizer-BioNTech | No |
| 2 | 2021-03-18 | Pfizer-BioNTech | No |
| 3 | 2022-01-07 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 successful
1 wait over 3 months for a first call
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Armpit pain/discomfort
Systemic reaction (other): Swollen lymph nodes (armpit) continue
Systemic reaction (other): Continued swollen lymph nodes (armpit)
Systemic reaction (other): Slight swelling of lymph nodes (armpit)
Systemic reaction (other): Continuing swollen lymph nodes (armpit) but much smaller, almost unnoticeable
Release 11 — day 14, dose 3
Symptoms: Pain in left shoulder & mid-back.
Release 11 — day 21, dose 3
Symptoms: Tiredness, insomnia, chest tightness (anxiety), migraine
Healthcare visit (other): in-person appointment
Release 11 — day 42, dose 3
Symptoms: Higher anxiety, a migraine (which I never get)
Healthcare visit (other): regular in-office appointment
Release 12 — 6 months, dose 3
Symptoms: Migraine
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Anxiety | · | · | ✓ |
| SD | Arthralgia | · | · | ✓ |
| SD | Back pain | · | · | ✓ |
| SD | Chest discomfort | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Insomnia | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SRO | Axillary pain | · | · | ✓ |
| SRO | Discomfort | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release